Cholera News and Research

Latest Cholera News and Research

West African cholera epidemic exacerbated by flooding; more than 1,800 deaths reported

The WHO says 1,879 deaths have been reported from cholera in Nigeria, Chad, Cameroon and Niger, the Associated Press reports. The wave of cholera started a few months ago and nearly 40,500 cases have been reported in the region so far. Nigeria alone has experienced nearly 1,200 deaths, its worst cholera outbreak in two decades, according to the article (10/12).

14 Oct 2010

NIAID awards $6.25M to Profectus to optimize portfolio of genetic adjuvants

Profectus BioSciences, Inc., a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases, today announced that it has received $6.25M in National Institute of Allergy and Infectious Disease (NIAID) grants and contracts.

8 Oct 2010

Johnson & Johnson to acquire all outstanding equity of Crucell for euro 1.75 billion

Johnson & Johnson and Crucell N.V. today announced an agreement whereby Johnson & Johnson, through an affiliate, would acquire all outstanding equity of Crucell that it does not already own for approximately euro 1.75 billion in a recommended cash tender offer.

6 Oct 2010

V.P. Biden pledges to 'sustain long-term' aid for Pakistan; U.S. concerned about aid branding

Vice President Joe Biden and British Deputy Prime Minister Nick Clegg recently said the U.S. and Britain would provide "'sustained long-term' support to Pakistani flood victims," Agence France-Presse reports.

28 Sep 2010

Opinions: Genetically-modified crops can improve vaccines; MDG focus on women and girls; U.S. leadership for MDGs; Boosting access to drugs; Merits of bilateral development assistance

"The U.N. estimates that diarrheal diseases kill 1.8 million people every year. … So you might take it as good news that American company Ventria Bioscience says it has hit on an improvement to existing rehydration therapies, which could mean another tool in the fight against diarrhea," according to a Wall Street Journal editorial examining the delays the company has experienced since it first sought to have its product approved by the FDA back in 2004, even "[a]fter a panel of food, medicine, immunology, child nutrition and health experts had declared its product safe."

23 Sep 2010

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35.

22 Sep 2010

Johnson & Johnson, Crucell announce advanced negotiations for potential public offer

Johnson & Johnson and Crucell N.V. today announced that they are in advanced negotiations for a potential public offer by Johnson & Johnson or an affiliate for all outstanding ordinary shares of Crucell not already held by Johnson & Johnson and its affiliates.

17 Sep 2010

395 new vaccines being developed for infectious diseases: PhRMA

Critical challenges remain in the centuries-old battles against infectious diseases, particularly as bacteria and viruses mutate and as the threat of bioterrorism grows. Responding to this need, America's biopharmaceutical research companies this year have 395 new medicines and vaccines in the pipeline to fight infectious diseases. All 395 are in later stages of development, meaning in clinical trials or under Food and Drug Administration (FDA) review.

10 Sep 2010

World Water Week kicks off with a focus on pollution, quality

A group of over 2,500 leading water experts from 130 countries gathered in Stockholm on Sunday to kick off World Water Week, where they will focus on "increasing water pollution and dwindling water quality around the globe," Agence France-Presse reports (Larson, 9/5).

7 Sep 2010

IMF, World Bank announce increased aid measures for flood relief in Pakistan

"The IMF and the World Bank have stepped up aid to flood-hit Pakistan to help the country cope with its worst-ever humanitarian disaster," Agence France-Presse reports.

4 Sep 2010

Biomagnetics to acquire Lanzhou New Sunshine Plastics Industry

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou New Sunshine Plastics Industry LTD. This expected acquisition is the fourth planned acquisition targeted at a share price of US $1.50 for Biomagnetics Diagnostics' common shares.

30 Aug 2010

Cameroon rolls out emergency cholera plan as region's outbreak continues

Cameroon will need approximately $4.8 million for its emergency response to the cholera outbreak, which has killed nearly 300 people in the northern part of the country, Agence France-Presse reports.

27 Aug 2010

Biomagnetics Diagnostics to acquire Hubei Tianyuan Chemical

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Hubei Tianyuan Chemical Co., Ltd. of Yangxin Nacheng Chemical Industry Zone, located in Hubei Province, China.

27 Aug 2010

Part of U.S. aid package for Pakistan will be redirected to fund flood rebuilding, USAID Administrator says

Part of the previously planned $7.5 billion U.S. aid package for Pakistan will be redirected to flood rebuilding projects, said USAID Administrator Rajiv Shah, the Associated Press reports. Shah also "warned that other nations would only contribute money if Islamabad could ensure it would be well spent."

26 Aug 2010

Cedarlane to distribute Pfenex's high value reagent proteins in Canada, U.S.

Pfenex Inc. and Cedarlane today announced that they have entered into a non-exclusive distribution agreement. Cedarlane will market and distribute high value reagent proteins produced by Pfenex to researchers in Canada and the United States.

25 Aug 2010

As flood waters spread, international aid for Pakistan tops $800M, foreign minister says

International donors have pledged more than $800 million to help Pakistan deal with severe flooding after the U.N. appealed for $460 million in aid, Shah Mahmood Qureshi, the country's foreign minister, said on Sunday, the Associated Press reports.

24 Aug 2010

'Yakult' effective in reducing acute diarrhea in young children: Study

YAKULT HONSHA CO., LTD. announced on August 20 that its collaborative study on the incidence of acute diarrhea with the National Institute of Cholera and Enteric Diseases in Kolkata, India, showed that daily intake of "Yakult" is efficacious in reducing the incidence of diarrhea in young children.

21 Aug 2010

Cholera outbreaks on the rise, WHO expert says

A recent increase in the number of cholera outbreaks is threatening populations in pockets of the world, Claire-Lise Chaignat, WHO's cholera group coordinator, said on Thursday, Agence France-Presse reports. "Cholera is transmitted by water but also by food that had been contaminated by unclean water," the news service writes. "It causes serious diarrhoea and vomiting, leading to dehydration. With a short incubation period, it can be fatal if not treated in time," AFP writes.

21 Aug 2010

U.S. boosts aid relief to Pakistani flood victims; U.N. donors meet about funding

Sen. John Kerry (D-Mass.) visited Pakistan on Thursday "to assess the damage and relief efforts" as flooding continues and millions remain in need of humanitarian aid, the New York Times reports. According to the newspaper, Kerry "said the United States would increase its flood aid to $150 million" (Masood/Gall, 8/19).

20 Aug 2010

Helping Hand for Relief and Development raises appeal to $5 million for Pakistan flood disaster

United Nations Secretary-General Ban Ki-moon said Sunday that amongst all the natural disasters he has witnessed, he has never seen anything like the disaster that has occurred due to the floods in Pakistan. The floods of Pakistan 2010 have been recorded as the worst natural disaster in the history.

19 Aug 2010

Cholera News and Research

Latest Cholera News and Research

West African cholera epidemic exacerbated by flooding; more than 1,800 deaths reported

NIAID awards $6.25M to Profectus to optimize portfolio of genetic adjuvants

Johnson & Johnson to acquire all outstanding equity of Crucell for euro 1.75 billion

V.P. Biden pledges to 'sustain long-term' aid for Pakistan; U.S. concerned about aid branding

Opinions: Genetically-modified crops can improve vaccines; MDG focus on women and girls; U.S. leadership for MDGs; Boosting access to drugs; Merits of bilateral development assistance

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Johnson & Johnson, Crucell announce advanced negotiations for potential public offer

395 new vaccines being developed for infectious diseases: PhRMA

World Water Week kicks off with a focus on pollution, quality

IMF, World Bank announce increased aid measures for flood relief in Pakistan

Biomagnetics to acquire Lanzhou New Sunshine Plastics Industry

Cameroon rolls out emergency cholera plan as region's outbreak continues

Biomagnetics Diagnostics to acquire Hubei Tianyuan Chemical

Part of U.S. aid package for Pakistan will be redirected to fund flood rebuilding, USAID Administrator says

Cedarlane to distribute Pfenex's high value reagent proteins in Canada, U.S.

As flood waters spread, international aid for Pakistan tops $800M, foreign minister says

'Yakult' effective in reducing acute diarrhea in young children: Study

Cholera outbreaks on the rise, WHO expert says

U.S. boosts aid relief to Pakistani flood victims; U.N. donors meet about funding

Helping Hand for Relief and Development raises appeal to $5 million for Pakistan flood disaster

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cholera News and Research

Latest Cholera News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in